2026 Publications

  1. Hidalgo LG, Madill-Thomsen KS, Reeve J, Investigators T-K, Halloran PF. Improving the histologic detection of DSA-negative antibody-mediated rejection in kidney transplants. Am J Transplant. 2025;26(1):117-130.
  2. Halloran PF, Reeve J, INTERCOMEX Investigators, and the Trifecta-Kidney Investigators. Impact of older donor age in kidney transplants: a biopsy-based observational study. Journal of Clinical Investigation Insight. 2025;11(12):e199060.
  3. Schatzl M, Mayer KA, Agis H, Haindl S, Kriks D, Fischer G, et al. T-Cell Engager-Mediated HLA Antibody Depletion before Kidney Transplantation. N Engl J Med. 2026;395(5):511-3.
  4. Mayer KA, Diebold M, Schrezenmeier EV, Halloran PF, Haindl S, Schatzl M, et al. Prolonged CD38 targeting with felzartamab in antibody-mediated kidney transplant rejection: a biomarker-guided open-label phase 2 extension. Lancet Reg Health Eur. 2026;68:101768.
  5. Gauthier PT, Gerhardt LMS, Jahn L, Hinze C, Halloran PF. Digital cytometry of leukocyte landscapes reveals shared correlates of rejection across organ transplants. Journal of Clinical Investigation. 2026; In press. 
  6. Gauthier PT, Mackova M, Hachem R, Havlin J, Hirji A, Jaksch P, et al. Molecular diagnosis of T cell-mediated rejection in bronchial mucosal and transbronchial biopsies. American Journal of Transplantation. 2026; In press.
  7. Girmanova E, Hruba P, Kollar M, Mackova M, Mrazova P, Bibik M, et al. Molecular Rejection Signatures in Pancreas Transplant Biopsies. Am J Transplant. 2026;26(7).